Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,913.00p
   
  • Change Today:
      59.00p
  • 52 Week High: 2,205.00
  • 52 Week Low: 1,722.00
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 369,709
  • Market Cap: £4,244.67m
  • RiskGrade: 125

HIK Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

Key Personnel

CEO: Riad Mishlawi
Executive Chairman: Said Darwazah
Executive Vice Chairman: Mazen Darwazah
Independent Non-Executive Director: Douglas Hurt
Independent Non-Executive Director: John J. Castellani
Independent Non-Executive Director: Laura Balan Balan
Independent Non-Executive Director: Mary (Nina) Henderson
Independent Non-Executive Director: Victoria Hull
Independent Non-Executive Director: Cynthia Schwalm
Independent Non-Executive Director: Deneen Vojta
Non-Executive Dir: Ali Al-Husry

Contact Details

Address: 1 New Burlington Place, London,United Kingdom, W1S 2HR
Phone: +44 (0)20 7399 2760
Fax: +44 (0)20 7399 2761
Website: http://www.hikma.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE 100, FTSE 350, FTSE All-Share
Overseas Listings: BATSLON:HIKL
ISIN: GB00B0LCW083

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,913.00p
Change Today 59.00p
% Change 3.18 %
52 Week High 2,205.00
52 Week Low 1,722.00
Volume 369,709
Shares Issued 221.89m
Market Cap £4,244.67m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
50.23% below the market average50.23% below the market average50.23% below the market average50.23% below the market average50.23% below the market average
52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average
Price Trend
21.47% above the market average21.47% above the market average21.47% above the market average21.47% above the market average21.47% above the market average
67.86% above the sector average67.86% above the sector average67.86% above the sector average67.86% above the sector average67.86% above the sector average
Income
39.42% above the market average39.42% above the market average39.42% above the market average39.42% above the market average39.42% above the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Growth
39.43% below the market average39.43% below the market average39.43% below the market average39.43% below the market average39.43% below the market average
22.22% below the sector average22.22% below the sector average22.22% below the sector average22.22% below the sector average22.22% below the sector average

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 21-Mar-24 10-Aug-23
Paid 03-May-24 15-Sep-23
Amount 47.00¢ 25.00¢

Trades for 26-Apr-2024

Time Volume / Share Price
16:39 181 @ 1,913.00p
16:35 231,053 @ 1,913.00p
16:35 414 @ 1,913.00p
16:35 534 @ 1,913.00p
16:35 489 @ 1,913.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page